Kazia Therapeutics Limited (KZIA)
NASDAQ·Healthcare·Biotechnology
$10.93
+2.16%
Mkt Cap $13.31M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$31.50
Range $25.00 – $40.00
Implied Upside
+188.3%
Consensus $31.50 vs current $10.93
NASDAQ·Healthcare·Biotechnology
$10.93
+2.16%
Mkt Cap $13.31M
No recent rating data.
Price Target (7 analysts)
$31.50
Range $25.00 – $40.00
+188.3%
Consensus $31.50 vs current $10.93